94 related articles for article (PubMed ID: 18630522)
1. Development of 36 clones producing human monoclonal antibodies specific to cancer cells and their ability to inhibit cancer cell growth.
Nakamura R; Saikawa Y; Hosokawa S; Fukuda K; Kumai K; Kubota T; Kitajima M; Kitagawa Y
Anticancer Res; 2008; 28(3A):1651-7. PubMed ID: 18630522
[TBL] [Abstract][Full Text] [Related]
2. A novel human monoclonal antibody derived from tumor-infiltrating lymphocytes in lung cancer inhibits cancer cell growth with morphological changes.
Aoki M; Saikawa Y; Hosokawa S; Fukuda K; Kumai K; Kubota T; Yoshida M; Otani Y; Kitajima M
Anticancer Res; 2005; 25(6B):3791-8. PubMed ID: 16309165
[TBL] [Abstract][Full Text] [Related]
3. Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer.
Ishiguro T; Sugimoto M; Kinoshita Y; Miyazaki Y; Nakano K; Tsunoda H; Sugo I; Ohizumi I; Aburatani H; Hamakubo T; Kodama T; Tsuchiya M; Yamada-Okabe H
Cancer Res; 2008 Dec; 68(23):9832-8. PubMed ID: 19047163
[TBL] [Abstract][Full Text] [Related]
4. Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients.
Brändlein S; Lorenz J; Ruoff N; Hensel F; Beyer I; Müller J; Neukam K; Illert B; Eck M; Müller-Hermelink HK; Vollmers HP
Hum Antibodies; 2002; 11(4):107-19. PubMed ID: 12775891
[TBL] [Abstract][Full Text] [Related]
5. Cancer and immune response: old and new evidence for future challenges.
de la Cruz-Merino L; Grande-Pulido E; Albero-Tamarit A; Codes-Manuel de Villena ME
Oncologist; 2008 Dec; 13(12):1246-54. PubMed ID: 19056856
[TBL] [Abstract][Full Text] [Related]
6. Photokilling cancer cells using highly cell-specific antibody-TiO(2) bioconjugates and electroporation.
Xu J; Sun Y; Huang J; Chen C; Liu G; Jiang Y; Zhao Y; Jiang Z
Bioelectrochemistry; 2007 Nov; 71(2):217-22. PubMed ID: 17643355
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody CC188 binds a carbohydrate epitope expressed on the surface of both colorectal cancer stem cells and their differentiated progeny.
Xu M; Yuan Y; Xia Y; Achilefu S
Clin Cancer Res; 2008 Nov; 14(22):7461-9. PubMed ID: 19010863
[TBL] [Abstract][Full Text] [Related]
8. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
Li B; VanRoey M; Wang C; Chen TH; Korman A; Jooss K
Clin Cancer Res; 2009 Mar; 15(5):1623-34. PubMed ID: 19208793
[TBL] [Abstract][Full Text] [Related]
9. Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies.
Vollmers HP; Brändlein S
Hum Antibodies; 2002; 11(4):131-42. PubMed ID: 12775893
[TBL] [Abstract][Full Text] [Related]
10. Targeting the stroma by T cells to limit tumor growth.
Zhang B
Cancer Res; 2008 Dec; 68(23):9570-3. PubMed ID: 19047130
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants.
Morera Y; Bequet-Romero M; Ayala M; Lamdán H; Agger EM; Andersen P; Gavilondo JV
Angiogenesis; 2008; 11(4):381-93. PubMed ID: 19034678
[TBL] [Abstract][Full Text] [Related]
12. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of monoclonal antibodies against human epidermal growth factor receptor in Balb/c mice.
Baradaran B; Hosseini AZ; Majidi J; Farajnia S; Barar J; Saraf ZH; Abdolalizadeh J; Omidi Y
Hum Antibodies; 2009; 18(1-2):11-6. PubMed ID: 19478394
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor effect of nanospheres coupled with the anti-human liver cancer monoclonal antibody HAb18].
Kan HP; Liu ZJ; Tan YF; Lin YX; Li CF; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1503-5. PubMed ID: 18753092
[TBL] [Abstract][Full Text] [Related]
15. Tumor resistance to specific lysis: a major hurdle for successful immunotherapy of cancer.
Chouaib S; Meslin F; Thiery J; Mami-Chouaib F
Clin Immunol; 2009 Jan; 130(1):34-40. PubMed ID: 19013109
[TBL] [Abstract][Full Text] [Related]
16. Preparation of antibody against horseradish peroxidase using hybridoma technology.
Asadi A; Pourfathollah AA; Mahdavi M; Eftekharian MM; Moazzeni SM
Hum Antibodies; 2008; 17(3-4):73-8. PubMed ID: 19029664
[TBL] [Abstract][Full Text] [Related]
17. The role of antibody in tumor immunity.
Economou JS
Surg Gynecol Obstet; 1981 Sep; 153(3):417-31. PubMed ID: 7268622
[TBL] [Abstract][Full Text] [Related]
18. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
[TBL] [Abstract][Full Text] [Related]
19. Imaging the immune response to monitor tumor immunotherapy.
Wang Q; Ornstein M; Kaufman HL
Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
